Early Breast Cancer Trialists Collaborative Group. The effects of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28 896 women
2. Early Breast Cancer Trialists Collaborative Group. The effects of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28 896 women. N Engl J Med. 1988;319:1681-1692.
Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer: analyses at six years
4. Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer: analyses at six years. Lancet. 1985;1:836-839.
Effects of tamoxifen in human breast cancer cell kinetics: accumulation of cells in early GI phase
6. Osborne CK, Boldt DH, Clark GM, Trent JM. Effects of tamoxifen in human breast cancer cell kinetics: accumulation of cells in early GI phase. Cancer Res. 1983;43:3583-3585.
Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
7. Sutherland RL, Green MD, Hall RE, Reddel R, Taylor IW. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur J Cancer Clin Oncol. 1983;19:615-621.
Lipid and lipoprotein effects of tamoxifen therapy in postmenopausal patients with node-negative breast cancer
10. Love RR, Newcomb PA, Wiebe DA, et al. Lipid and lipoprotein effects of tamoxifen therapy in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst. 1990;82:1327-1332.